Company Filing History:
2 out of 1,743 
1 out of 51 
Years Active: 2003-2015
Title: The Innovative Contributions of Dominique Aunis
Introduction
Dominique Aunis is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents. With a total of three patents to his name, Aunis has demonstrated a commitment to advancing medical science through innovation.
Latest Patents
Aunis's latest patents include groundbreaking work on peptidic antagonists of class III semaphorins/neuropilins complexes. This invention involves a peptidic antagonist that comprises an amino acid sequence derived from various proteins, including neuropilin-1 and integrin beta 2. The invention also encompasses a nucleic acid encoding for the peptidic antagonist, along with pharmaceutical compositions and their uses. Another significant patent focuses on the use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes. This invention includes a purified polypeptide or its biologically active derivatives, which are crucial for advancing cancer treatment.
Career Highlights
Throughout his career, Aunis has worked with esteemed organizations such as the National Institute of Health and Medical Research and Cis Bio International. His work in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical research.
Collaborations
Aunis has collaborated with notable colleagues, including François Degorce and Laurent Bellanger. These partnerships have played a vital role in the development of his innovative ideas and patents.
Conclusion
Dominique Aunis is a distinguished inventor whose work has significantly impacted the field of biomedical research. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.